Gapping down
In reaction to disappointing earnings/guidance:
- JT -5.5%, MYOV -3.5%, AMWD -0.5%
M&A news:
- GPN -4.1% (Total System & Global Payments (GPN) confirm $21.5 bln merger -- consideration reflects price per share of $119.86 for each share of TSYS common stock)
Select EU financial related names showing weakness:
- LYG -1.7%, DB -1.4%, BBVA -1.1%, HSBC -0.9%, SAN -0.7%, BCS -0.7%
Other news:
- KZR -23% (EULAR publishes abstract detailing data from the first two cohorts of an open-label dose escalation trial of KZR-616 in patients with systemic lupus erythematosus
- MYOV -3.5% (files mixed securities shelf offering and ~24K common share secondary offering by holders)
- TEAM -1.6% (co-CEOs Scott Farquhar and Mike Cannon-Brookes adopted new stock trading plans under Rule 10b5-1 to sell a portion of their stock over time)
- TD -1.1% (files for $45 bln mixed securities shelf offering)
- FDX -0.6% (Huawei is reviewing its relationship with FedEx
Analyst comments:
- GILD -2.2% (downgraded to Sell from Neutral at Goldman)
- OKTA -1.5% (downgraded to Neutral at Monness Crespi & Hardt)
- ROKU -0.6% (downgraded to Equal-Weight from Overweight at Stephens)